Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_assertion description "[TP53 mutations were identified in 9.1% of intermediate-grade IPMNs (2 of 22), 17.8% of PanIN-2 (8 of 45), 38.1% of high-grade IPMNs (8 of 21), 47.6% of PanIN-3 (10 of 21), and 75% of invasive pancreatic adenocarcinomas (15 of 20); no TP53 mutations were found in PanIN-1 lesions or low-grade IPMNs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_assertion evidence source_evidence_literature NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_assertion SIO_000772 23200980 NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_assertion wasDerivedFrom befree-2016 NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_assertion wasGeneratedBy ECO_0000203 NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1032648.RAsH2dGA6UF3GY36nVHUXzmFdx7p1eNEpDzJhYBR8vK_4130_provenance.